Profound Medical (PROF) vs SS Innovations International (SSII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Profound Medical (PROF) has outperformed SS Innovations International (SSII) over the past year, gaining 6.2% versus a loss of 78.7%. SS Innovations International is the larger company by market cap ($254.9 million vs $233.7 million), about 1.1 times the size. SS Innovations International converts more of its revenue into profit, with a net margin of -28.5% versus -264.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PROF | SSII |
|---|---|---|
| Share price | $6.38 | $1.27 |
| Market cap | $233.68M | $254.86M |
| 1-day change | -3.19% | -0.78% |
| YTD return | -18.93% | -77.64% |
| 1-year return | +6.16% | -78.69% |
| 5-year return | -43.64% | — |
| EPS (TTM) | $-0.94 | $-0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $16.10M | $42.48M |
| Revenue growth (YoY) | +50.73% | +105.74% |
| Net income (latest FY) | $-42.57M | $-12.13M |
| Gross margin | 70.77% | 46.00% |
| Operating margin | -256.27% | -19.29% |
| Net margin | -264.44% | -28.55% |
| 52-week high | $8.95 | $6.79 |
| 52-week low | $4.80 | $1.12 |
| Distance from 52-week high | -28.72% | -81.30% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +74.61% | +451.18% |
| Average volume | 208.29K | 86.18K |
| Shares outstanding | 36.63M | 200.68M |
| Employees | 162 | 483 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PROF has outperformed SSII by 84.8 percentage points over the past year.
- SS Innovations International is more profitable, keeping -28.5 cents of every revenue dollar as net income versus -264.4 cents for Profound Medical.
- SS Innovations International grew revenue faster in its latest fiscal year (+105.74% vs +50.73%).
About Profound Medical
PROF stock →Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.
Health Care · Medical/Dental Instruments · 162 employees
About SS Innovations International
SSII stock →SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.
Health Care · Medical/Dental Instruments · 483 employees
PROF vs SSII FAQ
Which is bigger, Profound Medical or SS Innovations International?
SS Innovations International (SSII) is larger, with a market capitalization of $254.86M compared with $233.68M for Profound Medical (PROF).
Which stock has performed better over the past year, PROF or SSII?
PROF returned +6.16% over the past 12 months, compared with -78.69% for SSII (price return, excluding dividends). Past performance does not predict future results.
Are Profound Medical and SS Innovations International in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.